Organization
Xiangya Hospital of Central South University
12 clinical trials
2 abstracts
Clinical trial
Efficacy and Safety of NSCLC Patients With or Without Adjuvant Immunotherapy Who Have Achieved Pathologic Complete Remission After Neoadjuvant Immunotherapy: A Prospective Real-World StudyStatus: Recruiting, Estimated PCD: 2027-09-01
Clinical trial
Efficacy and Safety Study of Cardunolizumab in Soft Tissue Sarcoma After Failure of at Least Anthracycline-based Chemotherapy: a Single-arm Clinical TrialStatus: Active (not recruiting), Estimated PCD: 2023-06-30
Clinical trial
Entacapone in Combination With Imatinib Mesylate for Treatment of Patients With Gastrointestinal Stromal Tumors(GIST) Following Failure of at Least Imatinib and SunitinibStatus: Completed, Estimated PCD: 2022-08-31
Clinical trial
A Open-label, Random, Multi-central Prospective Cohort of Observation Study on the Efficacy and Safety of Intraventricule Pemetrexed Disodium Via Ommaya ReservoirStatus: Recruiting, Estimated PCD: 2025-06-30
Clinical trial
A Clinical Study Exploring Lacosamide and Levetiracetam in Improving Cognitive in Patients With Alzheimer's Disease and EpilepsyStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Effect of Early Versus Late Initiation of Edaravone Dexborneol on Neural Function in Patients With Acute Ischemic Stroke-A Multicenter, Randomized, Double-blind, Placebo-controlled, TrialStatus: Not yet recruiting, Estimated PCD: 2024-12-31
Clinical trial
Clinical Multi-center Study of Mitochondrial Brain Protective Agent Idebenone in the Prevention of Post-stroke EpilepsyStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
A Single-arm, Open-label, Single-center Trial, Evaluating the Safety and Efficacy of BBM-P002 for Primary Advanced Parkinson's DiseaseStatus: Not yet recruiting, Estimated PCD: 2025-05-30
Clinical trial
Efficacy and Safety of Disitamab Vedotin Combined With Sintilimab in Second-line Treatment of Advanced Gastric Cancer: a Prospective, Single Arm Clinical Study (DVES)Status: Not yet recruiting, Estimated PCD: 2025-07-01
Clinical trial
Clinical Study of Neoadjuvant Chemotherapy and Immunotherapy Combined With Probiotics in Patients With Potential/Resectable Non-small Cell Lung CancerStatus: Active (not recruiting), Estimated PCD: 2027-09-01
Clinical trial
Comparing Efficacy and Safety of Mescaline Sodium Enteric-coated Tablets vs Morte-mescaline in the Treatment of Adult Lupus Nephritis: A Prospective, Multicenter,Real-world StudyStatus: Not yet recruiting, Estimated PCD: 2025-07-01
Clinical trial
Apatinib Mesylate Versus Standard Second-line TKI in the Treatment of Advanced Gastrointestinal Stromal Tumors: a Randomized, Open, Controlled, Single-center Clinical StudyStatus: Recruiting, Estimated PCD: 2026-01-01
Abstract
Safety and preliminary efficacy of YK-029A, a novel EGFR TKI, in patients with advanced NSCLC harboring ex20ins, T790M or rare mutations.Org: State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Science,Peking Union Medical College, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking University Cancer Hospital and Institute (Beijing Cancer Hospital), Beijing, China, Peking Union Medical College Hospital, Academy of Medical Sciences & Peking Union Medical College, Beijing, China,
Abstract
ALTERNATIVE SPLICING IDENTIFICATION IN SYSTEMIC SCLEROSIS AND THEIR ROLES IN SKIN FIBROSISOrg: Central South University, Changsha, China, Xiangya Hospital of Central South University, School of Computer Science and Engineering, Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, China, Medical Faculty of Heinrich Heine University,